ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes
- PMID: 20231558
- DOI: 10.7326/0003-4819-152-6-201003160-02004
ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes
Comment on
-
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.Ann Intern Med. 2009 Nov 17;151(10):703-15, W-226-35. doi: 10.7326/0003-4819-151-10-200911170-00147. Ann Intern Med. 2009. PMID: 19920271
Publication types
LinkOut - more resources
Full Text Sources